SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal resumes production at Taloja site

29 Oct 2019 Evaluate

Hikal has resumed normal production at Taloja site post the 100% restoration of water by MIDC. Pursuant to the Supreme Court order, MIDC has restored 100% supply of water to the Taloja MIDC zone on October 25, 2019. MIDC had cut 50% of the water supply last quarter which severely affected the operations in Q2 of FY20 resulting in lower production and sales.

Further, the Mahad site which was affected by heavy flooding in Q2FY20 resulting in a loss of production has also resumed normal production.

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries.

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×